Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07623564Enrolling By Invitation

Clinical Study on Tissue Preservation in Breast Augmentation and Reconstruction

Role: lead

NCT06274736Completed

Safety and Performance of Motiva® Sizers

Role: lead

NCT06146231Not ApplicableRecruiting

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Role: lead

NCT07135011Not ApplicableRecruiting

Adaptive Study to Assess the Safety and Functioning of Motiva Devices on Minimally Invasive Gluteal Augmentation

Role: lead

NCT06792409Not ApplicableCompleted

Mia® Clinical Study

Role: lead

NCT05459064Completed

Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction

Role: lead

NCT05447988Not ApplicableRecruiting

Motiva Flora Tissue Expander PMCF

Role: lead

All 7 trials loaded